Innoviva (INVA) FCF Payout Ratio Growth (1y) (2015 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.27% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 107.33% |
| Jun 30, 2022 | -49.30% |
| Mar 31, 2022 | -73.79% |
| Jun 30, 2021 | 56.46% |
| Mar 31, 2021 | 17.60% |
| Dec 31, 2020 | -81.31% |
| Jun 30, 2020 | 286,696.58% |
| Mar 31, 2020 | 206,097.86% |
| Dec 31, 2019 | 217.44% |
| Jun 30, 2019 | -99.68% |
| Mar 31, 2019 | -86.29% |
| Dec 31, 2018 | 745.56% |
| Sep 30, 2018 | 1,444.80% |
| Jun 30, 2018 | 842.11% |
| Mar 31, 2018 | -68.46% |
| Dec 31, 2017 | 90.22% |
| Sep 30, 2017 | -194.37% |
| Jun 30, 2017 | -82.26% |
| Mar 31, 2017 | -97.57% |
| Dec 31, 2016 | -88.58% |
| Sep 30, 2016 | -99.98% |
| Jun 30, 2016 | -99.93% |
| Mar 31, 2016 | 100.56% |
| Dec 31, 2015 | 100.45% |
| Sep 30, 2015 | 914.64% |